Literature DB >> 11413241

Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels.

J M Kulak1, J M McIntosh, D Yoshikami, B M Olivera.   

Abstract

It has previously been shown that nicotine-evoked dopamine release from rat striatal synaptosomes and nicotine-evoked norepinephrine release from hippocampal synaptosomes are mediated by distinct nicotinic acetylcholine receptor (nAChR) subtypes. In the present study, the functional association of these nicotinic receptors with specific subtypes of voltage-gated calcium channels was examined. Cd(2+) (200 microM), as well as omega-conotoxin MVIIC (5 microM), blocks approximately 85% of nicotine-evoked dopamine release from striatal synaptosomes, indicating a major involvement of calcium channels. Furthermore, the toxin-susceptibility suggests that these calcium channels contain alpha(1A) and/or alpha(1B) subunits. Inhibition of nicotine-evoked dopamine release by conotoxins alpha-MII and omega-GVIA is additive and indicates that presynaptic alpha3beta2 nAChRs are functionally coupled to alpha(1A), but not alpha(1B), calcium channel subtypes. Conversely, insensitivity to alpha-AuIB and sensitivity to omega-MVIIC indicate that non-alpha3beta2/alpha3beta4-containing nAChRs are functionally coupled to alpha(1B)-containing calcium channels. In contrast, Cd(2+) blocks only 65% of nicotine-evoked norepinephrine release from hippocampal synaptosomes, indicating that a substantial fraction of this release occurs through mechanisms not involving calcium channels. This Cd(2+)-insensitive component of release is blocked by alpha-AuIB and therefore appears to be triggered by Ca(2+) flowing directly through the channels of presynaptic alpha3beta4 nAChRs. Thus, these data indicate that different presynaptic termini can have distinctive functional associations of specific nAChRs and voltage-gated calcium channels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413241     DOI: 10.1046/j.1471-4159.2001.00357.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores.

Authors:  Ai-Hui Tang; Miranda A Karson; Daniel A Nagode; J Michael McIntosh; Victor N Uebele; John J Renger; Matthias Klugmann; Teresa A Milner; Bradley E Alger
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 3.  Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors.

Authors:  Bruce E McKay; Andon N Placzek; John A Dani
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

4.  Cross-regulation between colocalized nicotinic acetylcholine and 5-HT3 serotonin receptors on presynaptic nerve terminals.

Authors:  John J Dougherty; Robert A Nichols
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

5.  Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.

Authors:  Sulan Luo; Dongting Zhangsun; Xiaopeng Zhu; Yong Wu; Yuanyan Hu; Sean Christensen; Peta J Harvey; Muharrem Akcan; David J Craik; J Michael McIntosh
Journal:  J Med Chem       Date:  2013-11-22       Impact factor: 7.446

Review 6.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

7.  Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels.

Authors:  Henner Koch; Sebastien Zanella; Gina E Elsen; Lincoln Smith; Atsushi Doi; Alfredo J Garcia; Aguan D Wei; Randy Xun; Sarah Kirsch; Christopher M Gomez; Robert F Hevner; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

Review 8.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

Review 9.  Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system.

Authors:  Jian-xin Shen; Jerrel L Yakel
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 10.  Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

Authors:  Lauren C Smith; Olivier George
Journal:  Neuropharmacology       Date:  2020-08-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.